Background Recognizing the rapidly increasing interest and evidence in using metastasis-
directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO …

Purpose: The purpose of this study was to determine whether pulmonary oligometastases
from colorectal cancer have greater radioresistance than that of pulmonary oligometastases …

Purpose A systematic review of treatment characteristics, outcomes, and treatment-related
toxicities of stereotactic body radiation therapy (SBRT) for pulmonary oligometastases …

Importance Stereotactic ablative radiotherapy (SABR) is used for treating lung tumors but
can cause toxic effects, including life-threatening damage to central structures …

Background and purpose Recent studies have postulated that patients undergoing lung
stereotactic body radiotherapy (SBRT) for ultracentral tumors have higher toxicity and …

It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy
(SBRT) for lung oligometastases. A systematic review of literature with a priori selection …

This overview summarises the current evidence on efficacy and safety of single-fraction
stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung …

Background For stereotactic body radiotherapy (SBRT) to central (C) and ultracentral (UC)
lung tumors, our provincial practice has been to prioritize organs at risk (OARs) constraints …

Background Successful local therapy for oligometastases may lead to longer survival. The
purpose of this multicentre retrospective study was to investigate factors affecting the local …

Although systemic therapy is standard management for patients with metastatic disease,
several recent reports have indicated that an addition of local therapies including …